Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Treatment of cells with SB202190 significantly inhibits both basal and anti-Fas antibody-induced MAPKAPK 2 activity in a dose-dependent manner as measured in immune complex kinase assays with GST-hsp27 as a substrate
CAS Number: 119615-63-3
USP Tablets also contain the following inactive ingredients: colloidal silicon dioxide
Nintedanib
InChiKey: VHKZGNPOHPFPER-ONNFQVAWSA-N
Clozapine Catalog No.:M10647-2 Treatment of cells with SB202190Clozapine is an atypical antipsychotic drug because it binds to serotonin as well as dopamine receptors. Clozapine is a partial agonist at the 5 HT1A subunit of the serotonin receptor, putatively improving depression, anxiety, and the negative cognitive symptoms associated with schizophrenia. A direct interaction of clozapine with the GABAB receptor has also been shown. GABAB receptor deficient mice exhibit increased extracellular dopamine levels and
US$ 350.00
US$ 3161.45
US$ 463.11
US$ 17478.49
US$ 1599.73
US$ 699.50
US$ 520.02
US$ 200.00
US$ 308.04